Boothbay Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.42M | Buy |
+2,699
| New | +$1.42M | 0.03% | 437 |
|
|
2025
Q1 | – | Sell |
-12,375
| Closed | -$8.82M | – | 1532 |
|
|
2024
Q4 | $8.82M | Buy |
12,375
+11,239
| +989% | +$8.01M | 0.22% | 102 |
|
|
2024
Q3 | $1.19M | Buy |
+1,136
| New | +$1.19M | 0.03% | 574 |
|
|
2024
Q2 | – | Sell |
-5,081
| Closed | -$4.89M | – | 1607 |
|
|
2024
Q1 | $4.89M | Buy |
+5,081
| New | +$4.89M | 0.09% | 194 |
|
|
2023
Q3 | – | Sell |
-10,590
| Closed | -$7.61M | – | 1777 |
|
|
2023
Q2 | $7.61M | Buy |
10,590
+10,226
| +2,809% | +$7.35M | 0.17% | 90 |
|
|
2023
Q1 | $299K | Buy |
364
+80
| +28% | +$65.7K | 0.01% | 1284 |
|
|
2022
Q4 | $205K | Buy |
+284
| New | +$205K | ﹤0.01% | 1367 |
|
|
2020
Q3 | – | Sell |
-4,000
| Closed | -$2.5M | – | 1075 |
|
|
2020
Q2 | $2.5M | Sell |
4,000
-1,000
| -20% | -$624K | 0.17% | 127 |
|
|
2020
Q1 | $2.44M | Sell |
5,000
-2,000
| -29% | -$976K | 0.2% | 107 |
|
|
2019
Q4 | $2.63M | Sell |
7,000
-2
| -0% | -$751 | 0.23% | 94 |
|
|
2019
Q3 | $1.94M | Buy |
7,002
+887
| +15% | +$246K | 0.18% | 124 |
|
|
2019
Q2 | $1.91M | Buy |
+6,115
| New | +$1.91M | 0.17% | 114 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 803 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 757 |
|